Marc-Oliver Grimm Selected Research

Marc-Oliver Grimm Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 05/2002
30	Renal Cell Carcinoma (Grawitz Tumor) 09/2022 - 07/2009
13	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 02/2004
11	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 05/2002
6	Neoplasm Metastasis (Metastasis) 07/2022 - 11/2004
5	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
5	Non-Muscle Invasive Bladder Neoplasms 11/2021 - 01/2018
4	Transitional Cell Carcinoma 01/2022 - 02/2004
4	Disease Progression 01/2017 - 05/2004
3	Melanoma (Melanoma, Malignant) 01/2020 - 06/2017
2	Kidney Neoplasms (Kidney Cancer) 09/2022 - 01/2022
2	Lower Urinary Tract Symptoms 01/2018 - 05/2014
2	Overactive Urinary Bladder (Overactive Bladder) 01/2016 - 04/2010
1	Carcinogenesis 08/2021
1	Delayed Graft Function 06/2021
1	Neuroendocrine Carcinoma 09/2020
1	Fatigue 10/2019
1	Hypertension (High Blood Pressure) 10/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019
1	Urologic Neoplasms (Urological Cancer) 09/2019
1	Body Weight (Weight, Body) 04/2018
1	Lymphatic Metastasis 01/2018
1	Obesity 01/2018
1	Drug-Related Side Effects and Adverse Reactions 06/2017
1	Clinical Deterioration 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2016
1	Urinary Retention 03/2016

Drug/Important Bio-Agent (IBA)

15	NivolumabIBA 09/2022 - 01/2017
10	Sunitinib (Sutent)FDA Link 01/2022 - 02/2010
9	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
8	IpilimumabIBA 01/2022 - 06/2017
7	Messenger RNA (mRNA)IBA 01/2021 - 05/2002
6	AndrogensIBA 02/2022 - 09/2014
6	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2017
5	Everolimus FDA Link 05/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2005 - 05/2002
4	Pharmaceutical PreparationsIBA 11/2021 - 06/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2008
2	B7-H1 AntigenIBA 01/2022 - 09/2019
2	atraric acidIBA 01/2022 - 11/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2021 - 05/2008
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2014
2	Biological ProductsIBA 01/2021 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2004
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 09/2019
2	pazopanib FDA Link 01/2019 - 02/2010
2	Bevacizumab (Avastin)FDA Link 04/2018 - 02/2010
2	PlatinumIBA 01/2017 - 07/2009
2	ParaffinIBA 03/2014 - 05/2007
1	Complement System Proteins (Complement)IBA 09/2022
1	CateninsIBA 05/2022
1	Angiopoietin-2IBA 01/2022
1	sepantroniumIBA 01/2021
1	avelumabIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Untranslated Regions (Untranslated Region)IBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2020
1	Monoclonal AntibodiesIBA 09/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	temsirolimus FDA Link 01/2020
1	Alanine Transaminase (SGPT)IBA 10/2019
1	Amylases FDA Link 10/2019
1	Lipase (Acid Lipase)FDA Link 10/2019
1	Immune Checkpoint ProteinsIBA 09/2019
1	AntibodiesIBA 09/2019
1	Blocking AntibodiesIBA 09/2019
1	A-Form DNA (A-DNA)IBA 04/2019
1	Kisspeptin-1 ReceptorsIBA 04/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	lenvatinibIBA 04/2018
1	atezolizumabIBA 04/2018
1	cabozantinibIBA 04/2018
1	tivozanibIBA 04/2018
1	HydrogelsIBA 01/2018
1	Keratin-20 (Cytokeratin 20)IBA 09/2017
1	Insulin-Like PeptidesIBA 09/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2016

Therapy/Procedure

23	Therapeutics 09/2022 - 04/2010
6	Cystectomy 11/2021 - 05/2007
4	Nephrectomy 01/2022 - 07/2009
2	Immunotherapy 01/2022 - 04/2018
2	Castration 01/2022 - 08/2021
2	Intravesical Administration 11/2021 - 11/2020
2	Kidney Transplantation 06/2021 - 03/2016
2	Urinary Diversion (Ileal Conduit) 01/2018 - 03/2015
2	Drug Therapy (Chemotherapy) 01/2017 - 07/2009
2	Transurethral Resection of Prostate (TURP) 03/2016 - 05/2014
2	Lasers (Laser) 09/2011 - 07/2009
1	Lymph Node Excision (Lymph Node Dissection) 07/2022
1	Prostatectomy (Retropubic Prostatectomy) 07/2022
1	Sutures (Suture) 07/2022
1	Conservative Treatment 11/2021
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Microspheres (Microsphere) 01/2018
1	Neoadjuvant Therapy 01/2017
1	Retreatment 01/2016